| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |